Similar articles

• Metapristone suppresses non-small cell lung cancer proliferation and metastasis via modulating RAS/RAF/MEK/MAPK signaling pathway.

  Zheng G, Shen Z, Chen H, Liu J, Jiang K, Fan L, Jia L, Shao J. Zheng G, et al. Biomed Pharmacother. 2017 Jun;90:437-445. doi: 10.1016/j.biopha.2017.03.091. Epub 2017 Apr 6. Biomed Pharmacother. 2017. PMID: 28391165
• Growth factor-dependent activation of the Ras-Raf-MEK-MAPK pathway in the human pancreatic carcinoma cell line PANC-1 carrying activated K-ras: implications for cell proliferation and cell migration.

  Giehl K, Skripczynski B, Mansard A, Menke A, Gierschik P. Giehl K, et al. Oncogene. 2000 Jun 8;19(25):2930-42. doi: 10.1038/sj.onc.1203612. Oncogene. 2000. PMID: 10871844
• Retraction notice to "Corrigendum to 'LINC01116 targets miR-520a-3p and affects IL6R to promote the proliferation and migration of osteosarcoma cells through the Jak-stat signaling pathway'" [Biomed. Pharmacother. 111 (2019) 1508-1508].

  Zhang B, Yu L, Han N, Hu Z, Wang S, Ding L, Jiang J. Zhang B, et al. Biomed Pharmacother. 2024 Apr;173:116327. doi: 10.1016/j.biopha.2024.116327. Epub 2024 Mar 5. Biomed Pharmacother. 2024. PMID: 38448332 No abstract available.
• Cancer resistance to therapies against the EGFR-RAS-RAF pathway: The role of MEK.

  Martinelli E, Morgillo F, Troiani T, Ciardiello F. Martinelli E, et al. Cancer Treat Rev. 2017 Feb;53:61-69. doi: 10.1016/j.ctrv.2016.12.001. Epub 2016 Dec 30. Cancer Treat Rev. 2017. PMID: 28073102 Review.
• Is the Canonical RAF/MEK/ERK Signaling Pathway a Therapeutic Target in SCLC?

  Cristea S, Sage J. Cristea S, et al. J Thorac Oncol. 2016 Aug;11(8):1233-1241. doi: 10.1016/j.jtho.2016.04.018. Epub 2016 Apr 29. J Thorac Oncol. 2016. PMID: 27133774 Free PMC article. Review.